-
Endothelin-1 receptor antagonists in fetal development and pulmonary arterial hypertension.
Reproductive toxicology (Elmsford, N.Y.) 20150815
-
Ambrisentan for the treatment of adults with pulmonary arterial hypertension: a review.
Current medical research and opinion 20150101
-
AMBITION: An important piece in the therapeutic puzzle of pulmonary arterial hypertension.
Global cardiology science & practice 20150101
-
Lack of a clinically significant interaction of grapefruit juice with ambrisentan and bosentan in healthy adults.
International journal of clinical pharmacology and therapeutics 20141101
-
Interaction of ambrisentan with clarithromycin and its modulation by polymorphic SLCO1B1.
European journal of clinical pharmacology 20131001
-
Clinical pharmacokinetics and drug-drug interactions of endothelin receptor antagonists in pulmonary arterial hypertension.
Journal of clinical pharmacology 20121201
-
Frequency of edema in patients with pulmonary arterial hypertension receiving ambrisentan.
The American journal of cardiology 20121101
-
Safety and efficacy evaluation of ambrisentan in pulmonary hypertension.
Expert opinion on drug safety 20121101
-
Comparison of human ETA and ETB receptor signalling via G-protein and β-arrestin pathways.
Life sciences 20121015
-
Defining the affinity and receptor sub-type selectivity of four classes of endothelin antagonists in clinically relevant human cardiovascular tissues.
Life sciences 20121015
-
Endothelin receptor antagonists for the treatment of pulmonary artery hypertension.
Life sciences 20121015
-
The combination of theophylline and endothelin receptor antagonism improves exercise performance of rats under simulated high altitude.
Journal of applied physiology (Bethesda, Md. : 1985) 20121015
-
LC-ESI-MS/MS method for quantification of ambrisentan in plasma and application to rat pharmacokinetic study.
Biomedical chromatography : BMC 20121001
-
Long-term hepatic safety of ambrisentan in patients with pulmonary arterial hypertension.
Journal of the American College of Cardiology 20120703
-
Long-term safety and efficacy of ambrisentan in Japanese adults with pulmonary arterial hypertension.
Current medical research and opinion 20120601
-
Treatment of pulmonary arterial hypertension in connective tissue disease.
Drugs 20120528
-
Risk evaluation and mitigation strategies: assessment of a medical center's policies and procedures.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20120515
-
Chronic endothelin A receptor blockade attenuates contribution of sympathetic nervous system to salt hypertension development in adult but not in young Dahl rats.
Acta physiologica (Oxford, England) 20120501
-
Ambrisentan for pulmonary arterial hypertension: long term effects on clinical status, exercise capacity and haemodynamics.
International journal of cardiology 20120419
-
Endothelin-1 promotes cytoplasmic accumulation of RIP140 through a ET(A)-PLCβ-PKCε pathway.
Molecular and cellular endocrinology 20120404
-
ARIES-3: ambrisentan therapy in a diverse population of patients with pulmonary hypertension.
Cardiovascular therapeutics 20120401
-
eNOS deficiency acts through endothelin to aggravate sFlt-1-induced pre-eclampsia-like phenotype.
Journal of the American Society of Nephrology : JASN 20120401
-
Rapid determination of ambrisentan enantiomers by enantioselective liquid chromatography using cellulose-based chiral stationary phase in reverse phase mode.
Journal of separation science 20120401
-
Effect of cyclosporine and rifampin on the pharmacokinetics of macitentan, a tissue-targeting dual endothelin receptor antagonist.
The AAPS journal 20120301
-
Ambrisentan and tadalafil synergistically relax endothelin-induced contraction of rat pulmonary arteries.
Hypertension (Dallas, Tex. : 1979) 20120301
-
Synthesis of (+)-ambrisentan via chiral ketone-catalyzed asymmetric epoxidation.
The Journal of organic chemistry 20120106
-
Race and sex differences in response to endothelin receptor antagonists for pulmonary arterial hypertension.
Chest 20120101
-
Inhaled treprostinil: a therapeutic review.
Drug design, development and therapy 20120101
-
Pulmonary arterial hypertension: advances in pathophysiology and management.
Indian journal of pharmacology 20120101
-
A novel expression of exercise induced pulmonary hypertension in human immunodeficiency virus patients: a pilot study.
The open cardiovascular medicine journal 20120101
-
Treatment patterns and healthcare system burden of managed care patients with suspected pulmonary arterial hypertension in the United States.
Journal of medical economics 20120101
-
Smooth muscle myosin inhibition: a novel therapeutic approach for pulmonary hypertension.
PloS one 20120101
-
Slow receptor dissociation kinetics differentiate macitentan from other endothelin receptor antagonists in pulmonary arterial smooth muscle cells.
PloS one 20120101
-
Pulmonary arterial hypertension: an update.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 20111201
-
[Treatment of pulmonary fibrosis. New substances and new interventions].
Der Internist 20111201
-
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
PLoS computational biology 20111201
-
Adult congenital heart disease and pulmonary arterial hypertension: the Texas Adult Congenital Heart Program experience.
Postgraduate medicine 20111101
-
Macitentan: entry-into-humans study with a new endothelin receptor antagonist.
European journal of clinical pharmacology 20111001
-
Endothelin receptor antagonists -- their role in pulmonary medicine.
Revue des maladies respiratoires 20111001
-
Ambrisentan for sarcoidosis associated pulmonary hypertension.
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG 20111001
-
Efficacy, safety, and pharmacokinetics of ambrisentan in Japanese adults with pulmonary arterial hypertension.
Current medical research and opinion 20110901
-
Ambrisentan improves exercise capacity and symptoms in patients with portopulmonary hypertension.
Zeitschrift fur Gastroenterologie 20110901
-
Bosentan and oral anticoagulants in HIV patients: what we can learn of cases reported so far.
Hematology reports 20110831
-
Ambrisentan.
American journal of cardiovascular drugs : drugs, devices, and other interventions 20110801
-
Long-term pulmonary hemodynamic effects of ambrisentan in pulmonary arterial hypertension.
The American journal of cardiology 20110715
-
Endothelin receptor antagonists for the treatment of pulmonary arterial hypertension.
Expert opinion on pharmacotherapy 20110701
-
Synthesis and in vitro evaluation of ambrisentan analogues as potential endothelin receptor antagonists.
Bioorganic & medicinal chemistry letters 20110701
-
[Treatment of idiopathic pulmonary arterial hypertension].
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20110701
-
Differential modulation of the expression of important drug metabolising enzymes and transporters by endothelin-1 receptor antagonists ambrisentan and bosentan in vitro.
European journal of pharmacology 20110625
-
New perspectives for the treatment of pulmonary hypertension.
British journal of pharmacology 20110501
-
Novel therapeutic approaches for pulmonary fibrosis.
British journal of pharmacology 20110501
-
Ambrisentan for pulmonary arterial hypertension due to congenital heart disease.
The American journal of cardiology 20110501
-
With REMS, what goes up can come down.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20110501
-
Treprostinil increases the number and angiogenic potential of endothelial progenitor cells in children with pulmonary hypertension.
Angiogenesis 20110301
-
Survival after the initiation of combination therapy in patients with pulmonary arterial hypertension: an Australian collaborative report.
Internal medicine journal 20110301
-
Pharmacokinetic evaluation of ambrisentan.
Expert opinion on drug metabolism & toxicology 20110301
-
Hepatotoxicity by bosentan in a patient with portopulmonary hypertension: a case-report and review of the literature.
Journal of gastrointestinal and liver diseases : JGLD 20110301
-
[Changes long term prognosis of 17 patients with pulmonary artery hypertension].
Revista medica de Chile 20110301
-
Endothelin receptor antagonists as disease modifiers in systemic sclerosis.
Inflammation & allergy drug targets 20110201
-
Effects of multiple doses of ambrisentan on the pharmacokinetics of a single dose of digoxin in healthy volunteers.
Journal of clinical pharmacology 20110101
-
Safety and efficacy of ambrisentan for the treatment of portopulmonary hypertension.
Chest 20110101
-
Identification of clinically used drugs that activate pregnane X receptors.
Drug metabolism and disposition: the biological fate of chemicals 20110101
-
Availability of and access to orphan drugs: an international comparison of pharmaceutical treatments for pulmonary arterial hypertension, Fabry disease, hereditary angioedema and chronic myeloid leukaemia.
PharmacoEconomics 20110101
-
Effect of transition from sitaxsentan to ambrisentan in pulmonary arterial hypertension.
Vascular health and risk management 20110101
-
Pulmonary vascular complications of chronic liver disease: Pathophysiology, imaging, and treatment.
Annals of thoracic medicine 20110101
-
Short term effects of exercise training on exercise capacity and quality of life in patients with pulmonary arterial hypertension: protocol for a randomised controlled trial.
BMC pulmonary medicine 20110101
-
[Pulmonary arterial hypertension: changing approaches to management].
Kardiologiia 20110101
-
Recent trends in pulmonary arterial hypertension.
Lung India : official organ of Indian Chest Society 20110101
-
Therapeutic strategies in pulmonary hypertension.
Frontiers in pharmacology 20110101
-
Potent anti-inflammatory and antinociceptive activity of the endothelin receptor antagonist bosentan in monoarthritic mice.
Arthritis research & therapy 20110101
-
Does market exclusivity hinder the development of Follow-on Orphan Medicinal Products in Europe?
Orphanet journal of rare diseases 20110101
-
Diagnosis and management of pulmonary arterial hypertension.
Pulmonary medicine 20110101
-
Anaesthesia Management of Caesarean Section in Two Patients with Eisenmenger's Syndrome.
Anesthesiology research and practice 20110101
-
Diagnostic and therapeutic algorithm for pulmonary arterial hypertension.
Pulmonary circulation 20110101
-
Overview of current therapeutic approaches for pulmonary hypertension.
Pulmonary circulation 20110101
-
Vascular involvement in systemic sclerosis (scleroderma).
Journal of inflammation research 20110101
-
Assessment of daily life physical activities in pulmonary arterial hypertension.
PloS one 20110101
-
Endothelin Receptor Antagonists for the Treatment of Raynaud's Phenomenon and Digital Ulcers in Systemic Sclerosis.
International journal of rheumatology 20110101
-
Long-term effects of intravenous iloprost in patients with idiopathic pulmonary arterial hypertension deteriorating on non-parenteral therapy.
BMC pulmonary medicine 20110101
-
Effect and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis.
Pulmonary medicine 20110101
-
Surgical treatment of pulmonary hypertension: Lung transplantation.
Pulmonary circulation 20110101
-
Early intervention in pulmonary arterial hypertension associated with systemic sclerosis: an essential component of disease management.
European respiratory review : an official journal of the European Respiratory Society 20101201
-
The Adult Patient with Eisenmenger Syndrome: A Medical Update after Dana Point Part II: Medical Treatment - Study Results.
Current cardiology reviews 20101101
-
Potential for pharmacokinetic interactions between ambrisentan and cyclosporine.
Clinical pharmacology and therapeutics 20101001
-
Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses.
European heart journal 20100901
-
Evaluation of the endothelin receptor antagonists ambrisentan, darusentan, bosentan, and sitaxsentan as substrates and inhibitors of hepatobiliary transporters in sandwich-cultured human hepatocytes.
Canadian journal of physiology and pharmacology 20100601
-
Combined vasomodulatory therapy for severe pulmonary hypertension in chronic hypersensitivity pneumonitis.
Medical science monitor : international medical journal of experimental and clinical research 20100501
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20100501
-
[Pulmonary circulation: contributions of the year 2009].
Archivos de bronconeumologia 20100301
-
Long-term outcomes with ambrisentan monotherapy in pulmonary arterial hypertension.
Journal of cardiac failure 20100201
-
[Endothelin receptor antagonists in the new European guidelines on pulmonary hypertension].
Revue des maladies respiratoires 20100201
-
Pharmacotherapy in pulmonary arterial hypertension: a systematic review and meta-analysis.
Respiratory research 20100101
-
Pulmonary arterial hypertension in connective tissue diseases.
Cardiology in review 20100101
-
Hemodynamics in pulmonary arterial hypertension (PAH): do they explain long-term clinical outcomes with PAH-specific therapy?
BMC cardiovascular disorders 20100101
-
Oral Therapies for the treatment of pulmonary arterial hypertension: a population-based cost-minimization analysis.
Applied health economics and health policy 20100101
-
Portopulmonary hypertension.
Annals of thoracic medicine 20100101
-
Effect of steady-state ambrisentan on the pharmacokinetics of a single dose of the oral contraceptive norethindrone (norethisterone) 1 mg/ethinylestradiol 35 microg in healthy subjects: an open-label, single-sequence, single-centre study.
Clinical drug investigation 20100101
-
Pharmacotherapeutic management of pulmonary arterial hypertension.
Cardiology in review 20100101
-
The emergence of oral tadalafil as a once-daily treatment for pulmonary arterial hypertension.
Vascular health and risk management 20100101
-
Update on the clinical utility of sildenafil in the treatment of pulmonary arterial hypertension.
Drug design, development and therapy 20100101
-
Adult patients with pulmonary arterial hypertension due to congenital heart disease: a review on advanced medical treatment with bosentan.
Therapeutics and clinical risk management 20100101
-
Effects of rifampicin (rifampin) on the pharmacokinetics and safety of ambrisentan in healthy subjects: a single-sequence, open-label study.
Clinical drug investigation 20100101
-
Inhaled treprostinil and pulmonary arterial hypertension.
Vascular health and risk management 20100101
-
Phosphodiesterase-5 inhibitors in management of pulmonary hypertension: safety, tolerability, and efficacy.
Drug, healthcare and patient safety 20100101
-
No clinically relevant pharmacokinetic and safety interactions of ambrisentan in combination with tadalafil in healthy volunteers.
Journal of pharmaceutical sciences 20091201
-
Endothelin receptor antagonists for pulmonary hypertension in adult patients with sickle cell disease.
British journal of haematology 20091201
-
[Endothelin receptor antagonists - their role in pulmonary medicine].
Revue des maladies respiratoires 20091201
-
Long-term ambrisentan therapy for the treatment of pulmonary arterial hypertension.
Journal of the American College of Cardiology 20091117
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20091101
-
Can we improve outcome of congenital diaphragmatic hernia?
Pediatric surgery international 20090901
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20090901
-
Ambrisentan, an endothelin receptor type A-selective endothelin receptor antagonist, for the treatment of pulmonary arterial hypertension.
Expert opinion on pharmacotherapy 20090801
-
Use of inhaled iloprost in an infant with bronchopulmonary dysplasia and pulmonary artery hypertension.
Korean circulation journal 20090801
-
Effect of ketoconazole on the pharmacokinetic profile of ambrisentan.
Journal of clinical pharmacology 20090601
-
Pulmonary arterial hypertension: the most devastating vascular complication of systemic sclerosis.
Rheumatology (Oxford, England) 20090601
-
Small-molecule endothelin receptor antagonists: a review of patenting activity across therapeutic areas.
IDrugs : the investigational drugs journal 20090601
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20090601
-
The pharmacokinetics and pharmacodynamics of warfarin in combination with ambrisentan in healthy volunteers.
British journal of clinical pharmacology 20090501
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20090401
-
Ambrisentan: new drug. Too risky in mildly symptomatic pulmonary hypertension.
Prescrire international 20090401
-
A meta-analysis of randomized controlled trials in pulmonary arterial hypertension.
European heart journal 20090201
-
Ambrisentan therapy in patients with pulmonary arterial hypertension who discontinued bosentan or sitaxsentan due to liver function test abnormalities.
Chest 20090101
-
[Pulmonary arterial hypertension: a voyage around the year 2008].
Archivos de bronconeumologia 20090101
-
Pulmonary arterial hypertension in children: a medical update.
Indian journal of pediatrics 20090101
-
Review of inhaled iloprost for the control of pulmonary artery hypertension in children.
Vascular health and risk management 20090101
-
New concepts in the invasive and non invasive evaluation of remodelling of the right ventricle and pulmonary vasculature in pulmonary arterial hypertension.
The open respiratory medicine journal 20090101
-
Endothelin-1 inhibition by ambrisentan as a potential treatment adjunct after debulking surgery in epithelial ovarian cancer.
Oncology research 20090101
-
Treatment of pediatric pulmonary hypertension.
Vascular health and risk management 20090101
-
Oral therapies for the treatment of pulmonary arterial hypertension: a population-based cost-minimization analysis.
Applied health economics and health policy 20090101
-
Bosentan in the treatment of pulmonary arterial hypertension with the focus on the mildly symptomatic patient.
Vascular health and risk management 20090101
-
Cost-utility of treatments for pulmonary arterial hypertension: a Markov state-transition decision analysis model.
Clinical drug investigation 20090101
-
Safety and tolerability of bosentan in the management of pulmonary arterial hypertension.
Drug design, development and therapy 20090101
-
Therapeutic methods used in patients with Eisenmenger syndrome.
Cardiology journal 20090101
-
Integrated care and optimal management of pulmonary arterial hypertension.
Journal of multidisciplinary healthcare 20090101
-
Pharmacokinetics and safety of ambrisentan in combination with sildenafil in healthy volunteers.
Journal of clinical pharmacology 20081201
-
Ambrisentan and its role in the management of pulmonary arterial hypertension.
Drugs of today (Barcelona, Spain : 1998) 20081201
-
Role of ambrisentan in the management of pulmonary hypertension.
The Annals of pharmacotherapy 20081101
-
[Specific drugs for the treatment of pulmonary arterial hypertension - current status].
Deutsche medizinische Wochenschrift (1946) 20081001
-
Optimizing endothelin receptor antagonist use in the management of pulmonary arterial hypertension.
Vascular health and risk management 20081001
-
Pulmonary arterial hypertension: on the way to a manageable disease.
Current opinion in investigational drugs (London, England : 2000) 20080901
-
Inhibition of endothelin receptors in the treatment of pulmonary arterial hypertension: does selectivity matter?
European heart journal 20080801
-
[Current treatment of systemic sclerosis. Part II. Vascular and antifibrotic treatment].
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20080801
-
The management of pulmonary hypertension in children.
Archives of disease in childhood 20080701
-
Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2.
Circulation 20080610
-
The status of pulmonary arterial hypertension in 2008.
Circulation 20080610
-
[Systemic sclerosis].
Medizinische Monatsschrift fur Pharmazeuten 20080501
-
Ambrisentan for the management of pulmonary arterial hypertension.
Clinical therapeutics 20080501
-
[Treatment of pulmonary arterial hypertension by endothelin receptor antagonists in 2008].
La Revue de medecine interne 20080401
-
The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house?
British journal of pharmacology 20080301
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20080301
-
Endothelin receptor antagonists in pulmonary arterial hypertension.
The European respiratory journal 20080201
-
Acute right ventricular failure in the setting of acute pulmonary embolism or chronic pulmonary hypertension: a detailed review of the pathophysiology, diagnosis, and management.
Current cardiology reviews 20080201
-
Endothelin receptor antagonists for pulmonary arterial hypertension: rationale and place in therapy.
American journal of cardiovascular drugs : drugs, devices, and other interventions 20080101
-
Effects of selective and unselective endothelin-receptor antagonists on prostacyclin synthase gene expression in experimental pulmonary hypertension.
Scandinavian journal of clinical and laboratory investigation 20080101
-
Endothelin receptor antagonism: role in the treatment of pulmonary arterial hypertension related to scleroderma.
Drugs 20080101
-
Ambrisentan.
Drugs 20080101
-
Pulmonary hypertension: past, present and future.
Annals of thoracic medicine 20080101
-
Ambrisentan for the treatment of pulmonary arterial hypertension.
Drug design, development and therapy 20080101
-
Review of bosentan in the management of pulmonary arterial hypertension.
Vascular health and risk management 20071201
-
Ambrisentan (Letairis) for pulmonary arterial hypertension.
The Medical letter on drugs and therapeutics 20071022
-
Systematic review of randomised, double-blind clinical trials of oral agents conducted in patients with pulmonary arterial hypertension.
International journal of clinical practice 20071001
-
Expert opinion on available options treating pulmonary arterial hypertension.
Expert opinion on pharmacotherapy 20071001
-
Ambrisentan.
Nature reviews. Drug discovery 20070901
-
Therapeutic challenges for systemic sclerosis: facts and future targets.
Annals of the New York Academy of Sciences 20070901
-
New drug approved for pulmonary arterial hypertension.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070801
-
EndothelinA receptor antagonist BSF-208075 causes immune modulation and neuroprotection after stroke in gerbils.
Brain research 20070709
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20070401
-
Pathophysiological role of platelets in acute experimental pancreatitis: influence of endothelin A receptor blockade.
Cell and tissue research 20070301
-
Endothelin receptor antagonists in the treatment of pulmonary arterial hypertension.
Clinics in chest medicine 20070301
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20070301
-
A review of pulmonary arterial hypertension: role of ambrisentan.
Vascular health and risk management 20070201
-
Therapeutic targets in systemic sclerosis.
Arthritis research & therapy 20070101
-
New drugs: ambrisentan, temsirolimus, and eculizumab.
Journal of the American Pharmacists Association : JAPhA 20070101
-
[Pulmonary hypertension and right ventricular failure. Part XI. Endothelin receptor blockers in the treatment of primary pulmonary arterial hypertension].
Kardiologiia 20070101
-
Management of pulmonary arterial hypertension associated with congenital heart disease.
Romanian journal of internal medicine = Revue roumaine de medecine interne 20070101
-
Tadalafil: the evidence for its clinical potential in the treatment of pulmonary arterial hypertension.
Core evidence 20070101
-
[Treatment of pulmonary arterial hypertension: endothelin-receptor antagonists].
Deutsche medizinische Wochenschrift (1946) 20061208
-
Endothelin receptor antagonism in pulmonary arterial hypertension--a role for selective ET(A) inhibition?
Current medical research and opinion 20061201
-
Medical therapies for chronic thromboembolic pulmonary hypertension: an evolving treatment paradigm.
Proceedings of the American Thoracic Society 20060901
-
Endothelin receptor antagonists.
Pharmacology & therapeutics 20060601
-
Profile of past and current clinical trials involving endothelin receptor antagonists: the novel '-sentan' class of drug.
Experimental biology and medicine (Maywood, N.J.) 20060601
-
Endothelin antagonism prevents diabetic retinopathy in NOD mice: a potential role of the angiogenic factor adrenomedullin.
Experimental biology and medicine (Maywood, N.J.) 20060601
-
Attenuation of proinflammatory gene expression and microcirculatory disturbances by endothelin A receptor blockade after orthotopic liver transplantation in pigs.
Surgery 20060101
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20060101
-
Ambrisentan, a non-peptide endothelin receptor antagonist.
Cardiovascular drug reviews 20060101
-
Drug Insight: endothelin-receptor antagonists for pulmonary arterial hypertension in systemic rheumatic diseases.
Nature clinical practice. Rheumatology 20051201
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20051001
-
Ambrisentan therapy for pulmonary arterial hypertension.
Journal of the American College of Cardiology 20050802
-
Ambrisentan for pulmonary arterial hypertension.
Future cardiology 20050701
-
[Emerging therapies for the treatment of pulmonary arterial hypertension].
Herz 20050601
-
[Treatment algorithm for pulmonary arterial hypertension].
Herz 20050601
-
Improvement of postischemic hepatic microcirculation after endothelinA receptor blockade--endothelin antagonism influences platelet-endothelium interactions.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20050201
-
Drug treatment of pulmonary arterial hypertension: current and future agents.
Drugs 20050101
-
Effects of ET(A) receptor antagonism on proinflammatory gene expression and microcirculation following hepatic ischemia/reperfusion.
Microcirculation (New York, N.Y. : 1994) 20050101
-
Changes of vasoregulatory gene expression following hepatic ischemia/reperfusion and treatment with endothelin-A receptor blockade.
Journal of cardiovascular pharmacology 20041101
-
Endothelin-A receptor blockade improves postischemic hepatic microhemodynamics.
Journal of cardiovascular pharmacology 20041101
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20041001
-
Endothelin receptor antagonists in pulmonary arterial hypertension.
Journal of the American College of Cardiology 20040616
-
Endothelin receptor antagonists are not beneficial in the therapy of acute experimental pancreatitis.
Langenbeck's archives of surgery 20040601
-
Novel benzo[1,4]diazepin-2-one derivatives as endothelin receptor antagonists.
Journal of medicinal chemistry 20040520
-
Influence of a selective endothelin(A) receptor antagonist on the quantitative mRNA expression and the immunohistochemistry of vasoactive mediators after pancreas transplantation.
Transplantation proceedings 20030901
-
Cerebrovascular characterization of the novel nonpeptide endothelin-A receptor antagonist LU 208075.
Clinical neuropharmacology 20030101
-
Ambrisentan (Myogen).
Current opinion in investigational drugs (London, England : 2000) 20021001
-
Administration of a selective endothelin-a receptor antagonist (BSF 208075) improves hepatic warm ischemia/reperfusion injury in pigs.
Transplantation proceedings 20020901
-
Effect of the novel endothelin(A) receptor antagonist LU 208075 on contraction and relaxation of isolated rat basilar artery.
Clinical science (London, England : 1979) 20020801
-
Endothelin A-receptor blockade in experimental diabetes improves glucose balance and gastrointestinal function.
Clinical science (London, England : 1979) 20020801